Advertisement

Rheumatology International

, Volume 37, Issue 12, pp 1999–2004 | Cite as

Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus

  • Eduardo de Almeida MacêdoEmail author
  • Simone Appenzeller
  • Lilian Tereza Lavras Costallat
Validation Studies

Abstract

Neuropsychiatric lupus (NPSLE) is described in 12–95% of patients with systemic lupus erythematosus (SLE). Anxiety disorders are among the most frequent manifestations of NPSLE, occurring in 4–85% of these patients. Several diagnostic tools, such as Hospital Anxiety and Depression Scale (HADS), have been used to assess anxiety in clinical studies in SLE, but there is a lack of data on the performance of these questionnaires in the disease. This study aimed to assess the performance of HADS for the detection of anxiety in male and female patients with SLE, also investigating possible gender differences in this aspect. This study included 54 male SLE patients and 54 female SLE patients. The Diagnostic Criteria for Generalized Anxiety Disorder of the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders was used as gold-standard method to assess the performance of HADS for detecting anxiety in SLE patients. HADS presented sensitivity of 88.9% and specificity of 92.6%, with positive and negative predictive values of 80.0 and 96.1%, respectively. The HADS accuracy in total sample was 92.6%, with Kappa coefficient equal to 0.5794 (95% CI 0.3894–0.7695). No significant differences were observed between female and male groups regarding the performance of HADS for diagnosing anxiety.

Keywords

Systemic lupus erythematosus Anxiety Hospital Anxiety and Depression Scale 

Notes

Compliance with ethical standards

Conflict of interest

Eduardo de Almeida Macêdo: the author declares that he has no conflict of interest. Simone Appenzeller: the author declares that she has no conflict of interest. Lilian Tereza Lavras Costallat: the author declares that she has no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Wallace DJ, Hahn BH (2013) Dubois lupus erythematosus and related syndromes, 8th edn. Elsevier, PhiladelphiaGoogle Scholar
  2. 2.
    Hanly JG (2011) The nervous system and lupus. Systemic lupus erythematosus, 5th edn. Elsevier, San Diego, pp 727–746CrossRefGoogle Scholar
  3. 3.
    Jeltsch-David H, Muller S (2014) Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 10(10):579–596. doi: 10.1038/nrneurol.2014.148 CrossRefPubMedGoogle Scholar
  4. 4.
    Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, Ceruti S, Trotta F (2016) The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun 74:41–72. doi: 10.1016/j.jaut.2016.06.013 CrossRefPubMedGoogle Scholar
  5. 5.
    Pamfil C, Fanouriakis A, Damian L, Rinzis M, Sidiropoulos P, Tsivgoulis G, Rednic S, Bertsias G, Boumpas DT (2015) EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology 54(7):1270–1278. doi: 10.1093/rheumatology/keu482 CrossRefPubMedGoogle Scholar
  6. 6.
    ACR Ad Hoc Committee of Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42(4):599–608. doi: 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F CrossRefGoogle Scholar
  7. 7.
    Palagini L, Mosca M, Tani C, Gemignani A, Mauri M, Bombardieri S (2013) Depression and systemic lupus erythematosus: a systematic review. Lupus 22(5):409–416. doi: 10.1177/0961203313477227 CrossRefPubMedGoogle Scholar
  8. 8.
    Iverson GL, Sawyer DC, McCracken LM, Kozora E (2001) Assessing depression in systemic lupus erythematosus: determining reliable change. Lupus 10(4):266–271CrossRefPubMedGoogle Scholar
  9. 9.
    Bachen EA, Chesney MA, Criswell LA (2009) Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 61(6):822–829. doi: 10.1002/art.24519 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Zhang L, Fu T, Yin R, Zhang Q, Shen B (2017) Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry 17(1):70. doi: 10.1186/s12888-017-1234-1 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, Yilmaz N, Tuglular S, Direskeneli H (2015) Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Exp Rheumatol 33(3):360–365PubMedGoogle Scholar
  12. 12.
    Shen B, Tan W, Feng G, He Y, Liu J, Chen W, Huang X, Da Z, Xu X, Liu H, Gu Z (2013) The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol 2013:270878. doi: 10.1155/2013/270878 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMedGoogle Scholar
  14. 14.
    Botega NJ, Bio MR, Zomignani MA, Garcia C Jr, Pereira WAB (1995) Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Públ 29(5):355–363CrossRefGoogle Scholar
  15. 15.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277CrossRefPubMedGoogle Scholar
  16. 16.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. doi: 10.1002/1529-0131(199709)40:9<1725:AID-ART29>3.0.CO;2-Y CrossRefPubMedGoogle Scholar
  17. 17.
    American Psychiatric Assotiation (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, ArlingtonCrossRefGoogle Scholar
  18. 18.
    Associação Brasileira de Empresas de Pesquisa-ABEP (2014) Critério de Classificação Econômica Brasil. http://www.abep.org/criterio-brasil. Accessed 02 Jan 2014
  19. 19.
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640CrossRefPubMedGoogle Scholar
  20. 20.
    Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP, Trial O-S (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353(24):2550–2558. doi: 10.1056/NEJMoa051135 CrossRefPubMedGoogle Scholar
  21. 21.
    Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369CrossRefPubMedGoogle Scholar
  22. 22.
    Fleiss JL (1981) Statistical methods for rates and proportions, 2nd edn. Wiley, New YorkGoogle Scholar
  23. 23.
    Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMedGoogle Scholar
  24. 24.
    Statistical Analysis System Institute Inc (2013) SAS 9.4 Procedures Guide. SAS Institute Inc, Cary, NCGoogle Scholar
  25. 25.
    Yang Y, Ding R, Hu D, Zhang F, Sheng L (2014) Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients. Compr Psychiatry 55(1):215–220. doi: 10.1016/j.comppsych.2013.08.012 CrossRefPubMedGoogle Scholar
  26. 26.
    Mitchell AJ, Meader N, Symonds P (2010) Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord 126(3):335–348. doi: 10.1016/j.jad.2010.01.067 CrossRefPubMedGoogle Scholar
  27. 27.
    Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR (2013) Kelley’s textbook of rheumatology, vol II, 9th edn. Elsevier, PhiladelphiaGoogle Scholar
  28. 28.
    Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (2015) Rheumatology, vol II, 6th edn. Elsevier, PhiladelphiaGoogle Scholar
  29. 29.
    Tan TC, Fang H, Magder LS, Petri MA (2012) Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 39(4):759–769. doi: 10.3899/jrheum.111061 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Macedo EA, Appenzeller S, Costallat LT (2016) Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Lupus. doi: 10.1177/0961203316638934 PubMedGoogle Scholar
  31. 31.
    Nanthakumar S, Bucks RS, Skinner TC (2016) Are we overestimating the prevalence of depression in chronic illness using questionnaires? Meta-analytic evidence in obstructive sleep apnoea. Health Psychol 35(5):423–432. doi: 10.1037/hea0000280 CrossRefPubMedGoogle Scholar
  32. 32.
    Toups M, Carmody T, Trivedi MH, Rush AJ, Hedayati SS (2016) Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis. Gen Hosp Psychiatry 42:60–66. doi: 10.1016/j.genhosppsych.2016.07.005 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Department of MedicineHospital de Clínicas da Universidade Estadual de Campinas (UNICAMP)-Disciplina de ReumatologiaCampinasBrazil

Personalised recommendations